PlasmaBiological AvailabilityHalf-LifeArea Under CurveAdministration, OralDelayed-Action PreparationsOxprenololAntineoplastic AgentsDose-Response Relationship, DrugInjections, IntravenousDrug Screening Assays, AntitumorMorphinansMetabolic Clearance RateXenograft Model Antitumor AssaysChromatography, High Pressure LiquidDrug Administration ScheduleCross-Over StudiesInfusions, IntravenousTime FactorsDrug InteractionsBenzoxazinesSaquinavirPharmacokineticsDouble-Blind MethodDrug MonitoringPlasma CellsRitonavirNevirapineCell Line, TumorModels, BiologicalAnti-HIV AgentsAbsorptionTissue DistributionLeukemia P388Antibiotics, AntineoplasticMice, NudeNeoplasms, ExperimentalNeoplasm TransplantationSarcoma 180PyridinesDogsMelanoma, ExperimentalCell MembraneAntifungal AgentsBlood PressureHIV InfectionsHeart RatePlasma GasesMice, Inbred BALB CTumor Cells, CulturedCancer VaccinesNeoplasmsMice, Inbred C57BLTreatment OutcomeLeukemia L1210Anti-Bacterial AgentsImmunotherapyKineticsPlasma VolumeDrug SynergismApoptosisImmunotherapy, AdoptivePlasma ExchangeCell ProliferationAntibodies, MonoclonalEnediynesMice, SCIDAntineoplastic Agents, PhytogenicTransplantation, HeterologousAntigens, NeoplasmLiverCarcinoma, Lewis LungCell SurvivalInjections, IntralesionalGenetic TherapyMelanomaLung NeoplasmsCholesterolCytotoxicity, ImmunologicSarcoma, ExperimentalOncolytic VirotherapyColonic NeoplasmsCD8-Positive T-LymphocytesFibrosarcomaT-Lymphocytes, CytotoxicCell LineCell DivisionBiological MarkersFlow CytometryAngiogenesis InhibitorsOncolytic VirusesAdenoviridaeTumor BurdenInhibitory Concentration 50Dendritic CellsMolecular Sequence DataKiller Cells, NaturalBlood GlucoseTriglyceridesDoxorubicin